Special Feature The Seven-Billion Society: What's In It For Pharma?
On Monday, the world’s population hit the 7 billion mark. The UN estimates that this figure will reach just under 10 billion by 2050. More interesting than the numbers themselves are the implications of this growth — especially for pharma and healthcare ...Read More
Economy What Pharma Could Do for 'Occupy Wall Street'
Ben Comer asks if New York’s Occupy Wall Street (OWS) protestors, as they struggle against the elements, would be willing to accept a gift of bandages, pain relievers, decongestants and other products from pharma ...Read More
Patient Advocacy Going Global: The Next Stage For Patient Engagement?
All major players in the pharmaceutical industry are multi-national organizations. Patient organizations, on the other hand, rarely cross borders. Maybe it’s time they should. Certainly the pace of change in our industry is heading in that direction ...Read More
Advertisement Leadership and Strategy in Pharmaceuticals and Biotech http://www.exed.hbs.edu/programs/lspb/Pages/default.aspx
Revolutions in technology, markets, and government policy are transforming the playing field for pharmaceutical and biotechnology companies. This program prepares high-potential executives to become better managers and leaders by presenting new ways to manage risk, foster innovation, and capitalize on emerging opportunities.
Global Coalition Takes On Tropical Diseases
A new consortium of public and private sector organizations spearheaded by the World Intellectual Property Organization (WIPO)—dubbed WIPO Re:Search—aims to promote the development of new vaccines, drugs, and diagnostics to treat neglected tropical diseases through intellectual property (IP) sharing ...Read more
Advertisement CBI's 9th Annual Specialty Pharmaceuticals, Oral Therapies and Injectables
Don't forget - Mention Promo Code KNP237 and save $400! http://www.cbinet.com/specialty
Join thought leaders from the healthcare and pharmaceutical industry to share best practices for specialty drug management.
Benefits of Attending:
Annual Pipeline Update for Specialty Pharmaceuticals
Employer's Perspective on Measuring Costs and Outcomes
Optimal Drug Contract Design in Specialty Pharmaceuticals
Healthcare Reform Make Your Suggestions For Medicare/Medicaid Reform
The Center for Medicare and Medicaid Innovation (CMMI) is now accepting applications for its Innovation Advisors Program. The CMMI, created by the Affordable Care Act, is tasked with “testing new models of healthcare delivery and payment” ...Read more
// Sanofi appointed David Meeker as Chief Executive Officer of its biotech acquisition, Genzyme (Cambridge, Mass.) // Biopharm company NeurogesX, Inc. (San Mateo, Calif.) appointed Stephen J. Peroutka, M.D., Ph.D., as Executive Vice President (EVP), and Chief Medical Officer (CMO).// Theorem Clinical Research (King of Prussia, PA), previously Omnicare Clinical Research, announced that Adam Serody has joined the company as Vice President, Global Business Development.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
